Arkolith/Insider Trading/TERN/Form 4

Burroughs Amy L.

Chief Executive Officer, DirectorTerns Pharmaceuticals, Inc. (TERN) · full profile →Form 4 · filed Jun 25, 2025
Net Buying
Open-Market Buys
$90K
Open-Market Sells
$0
Net Open-Market Flow
$90K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 25, 2025Buy(P)23K$3.87$90K47K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-005077) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML